Donate

We are officially recognized by the IRS as a 501(c)(3) non-profit organization

DONATIONS ARE TAX-DEDUCTIBLE

Your contributions support The Cure Alliance in our efforts to help accelerate cures of chronic, debilitating and fatal diseases. Our membership  promotes knowledge sharing among scientists,  researchers, medical doctors and innovators. Our leadership works to identify and tear down the many barriers they face in moving potential cures from the laboratory to the bedside.

JavaScript is not enabled. You must enable JavaScript to use this form.

Donation Information

I would like to make a donation in the amount of:

$1,000$500$200$100$50Other

Tribute Gift

Check here to donate in honor or memory of someone

Donor Information

First Name:
Last Name:
Email:
Please do not display my name publicly. I would like to remain anonymous
Add me to your mailing list
Phone:
Occupation:

 

“Isn’t it time we cured your disease… and everyone else’s?”

 

Please Think Before You Go Pink

UPDATED:  It’s my least favorite time of year: October and its onslaught of pink ribbons, the great con on the American public who believe  by buying “pink” products they are advocating in the fight against breast cancer. I have earned the right to protest as a long-time investigative  journalist, a

Read More >>

YOUR CURE ALLIANCE AT WORK

Cure Alliance President Shelley Ross Asks FDA to Eliminate Restrictions on Breast Cancer Reconstruction from New Guidelines on Fat Transfer Thank you for the invitation to speak today as president of The Cure Alliance, a non-profit group of leading translational researchers, surgeons, innovators and those who support our efforts to

Read More >>

Fixing Patent Laws to Cure Disease? Why, It’s Genius!

MIT Economist Heidi Williams Wins MacArthur Foundation “Genius” Grant for Exposing Invisible Barriers to Cures Since its creation, The Cure Alliance has pointed to the need to reform patent laws as a key barrier to curing disease.  We have exposed the three-year backlog in the U.S. Patent Office, the issue

Read More >>